On April 29, the Joint Committee on Financial Services heard both H1091 and S800, Acts Relative to Pharmacists as Health Care Providers. These bills would authorize the Department of Public Health to allow pharmacists to order, test, screen and treat patients. H1091 and S800 would also require pharmacies to be reimbursed for services. NACDS submitted testimony and will continue to support the bill throughout the legislative session which ends July 31, 2026.    

Also in Massachusetts, the Board of Pharmacy released three updates:  

Policy 2025-01: Rapid Microbial Methods (Rapid Sterility Testing) 

Outlines general considerations and requirements for compounding pharmacies contemplating the use of an alternative sterility testing method. 

  

Policy 2022-02: Extended Absence or Departure of a Manager of Record or Designated Pharmacist-in-Charge 

Addresses non-resident Designated PIC absences and departures. 

  

Opioid REMS Program 

Pharmacies can order take-back envelopes and access other information on this website. 

For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.